Experiment 620868

Worktypes

EFFECTS DUE TO A COMBINATION OF DRUGSANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)PHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

CICHORIC ACID,L:

Alerts

A MIXTURE OF PURE COMPOUNDS WAS USED TO OBTAIN THE REPORTED EFFECT.

Details

PropertyValue
Pharmacology
ANTIVIRAL ACTIVITY
OrganismEmpty organism
CitationROBINSON JR,WE:. (1998). L-CHICORIC ACID, AN INHIBITOR OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1)-INTEGRASE, IMPROVES ON THE IN VITRO ANTI-HIV-1 EFFECT OF ZIDOVUDINE PLUS A PROTEASE INHIBITOR (AG1350).. 39(2)
Amount utilized
Compound isolated
DiseaseCMPD IN COMBINATION WITH DRUG ZIDOVUDINE AND PROTEASE INHIBITOR IMPROVED ANTIVIRAL ACTIVITY.
Dose amount1.0 MICROMOLS
Number1
Qualitative resultACTIVE
AnimalCELL CULTURE
Dose expressionCONC USED